PXMD — PaxMedica Cashflow Statement
0.000.00%
- $0.01m
- -$0.31m
Annual cashflow statement for PaxMedica, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.599 | -7.83 | -10.2 | -14.8 | -18.3 |
Non-Cash Items | 0.063 | 4.52 | 4.36 | 8.68 | 7.19 |
Unusual Items | |||||
Purchased R&D | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.117 | 0.962 | 0.352 | 0.05 | 0.334 |
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -0.419 | -2.35 | -5.51 | -6.07 | -10.8 |
Other Investing Cash Flow Items | 0 | — | — | — | — |
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0 | — | — | — | — |
Financing Cash Flow Items | 0.435 | 0.52 | 4.83 | 0 | -0.319 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.435 | 3.45 | 4.83 | 7.53 | 13.6 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.016 | 1.1 | -0.68 | 1.46 | 2.81 |